By targeting molecules that bind to radionuclides, RDCs are widely used as precision therapeutic strategies for cancer.
Customized design of RDC, combining targeting molecules with radionuclides to enhance cancer therapy effectiveness.
Learn More →Precise conjugation of radionuclides to targeting molecules, forming RDC for enhanced cancer therapy effectiveness.
Learn More →Analysis of RDC physicochemical properties, ensuring stability, purity, and optimal performance.
Learn MoreTesting RDC in cell-based assays to assess efficacy, specificity, and cytotoxicity.
Learn MoreEvaluating RDC in animal models for biodistribution, safety, and therapeutic efficacy.
Learn MoreAlfa Cytology offers efficient, customized, and professional R&D services related to radionuclide drug conjugates.